CKD Strongest Risk Factor for Sudden Cardiac Arrest in Hispanics/Latinos
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 12, 2023 -- For Hispanic or Latino adults, chronic kidney disease is the strongest risk factor for sudden cardiac arrest (SCA), according to a study published online Oct. 11 in the Journal of the American Heart Association.
Kyndaron Reinier, Ph.D., M.P.H., from the Cedars-Sinai Health System in Los Angeles, and colleagues examined predictors of SCA risk among Hispanic or Latino individuals in the United States. A total of 1,468 adult SCA cases were ascertained from the Ventura Prediction of Sudden Death in Multi-Ethnic Communities study, and control participants were selected from 3,033 Hispanic or Latino participants at the San Diego site of the Hispanic Community Health Survey/Study of Latinos (HCHS/SOL). The analyses included 295 Hispanic or Latino SCA cases and 590 frequency-matched HCHS/SOL controls.
The researchers found that in models adjusted for age, sex, and other clinical variables, chronic kidney disease, heavy drinking, stroke, atrial fibrillation, coronary artery disease, heart failure, and diabetes were associated with SCA (odds ratios [95 percent confidence intervals], 7.3 [3.8 to 14.3], 4.5 [2.3 to 9.0], 3.1 [1.2 to 8.0], 3.7 [1.7 to 7.9], 2.9 [1.5 to 5.9], 2.5 [1.2 to 5.1], and 1.5 [1.0 to 2.3], respectively).
"These findings provide information that could be useful in designing public health and medical interventions to reduce SCA risk among Hispanic or Latino individuals," the authors write. "Because of the strong association of kidney disease with SCA in our study, early identification and management of chronic kidney disease could reduce risk of SCA among Hispanic or Latino individuals."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
Women Face Worse Chronic Kidney Disease Management in Primary Care
MONDAY, May 20, 2024 -- Women receive worse primary care-based chronic kidney disease (CKD) management than men, according to a research letter published online May 16 in the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.